苏格兰将于2026年3月开始对新生儿进行SMA查,使用常规血液检测以实现早期治疗和预防残疾. Scotland begins newborn SMA screening in March 2026, using routine blood tests to enable early treatment and prevent disability.

苏格兰已经启动了脊柱肌肉缩 (SMA) 新生儿查计划,成为英国第一个这样做的地区. Scotland has launched a newborn screening program for spinal muscular atrophy (SMA), becoming the first UK region to do so. 从2026年3月开始,所有新生儿都使用现有的四日血点检测进行检查,以便在出现症状之前发现SMA,从而能够及早治疗并预防严重残疾. Starting in March 2026, all newborns are tested using the existing day-four blood spot test to detect SMA before symptoms appear, enabling early treatment that can prevent severe disability. 这项为期两年的试点项目由苏格兰政府和诺华公司资助, 旨在改善长期的结果. 父母和医疗专家称之为改变生活的一步. Funded by the Scottish Government and Novartis, the two-year pilot aims to improve long-term outcomes, with parents and medical experts calling it a life-changing step. 这项倡议是多年来一直在推广的, 并且可以作为英国其他地区的典范. The initiative follows years of advocacy and could serve as a model for the rest of the UK.